To stimulate innovation, economic activity and entrepreneurship in both education and research, IXA has, in collaboration with the City of Amsterdam, developed the valorisation programme IXAnext: Talent for Innovation.
IXAnext is an alliance between the Amsterdam universities and knowledge institutes: HvA, UvA, VU, VUmc and AMC and the NWO institutes AMOLF and NIKHEF. Over a five-year period, 2017-2021, they collaborate in utilising and disseminating knowledge. The programme offers facilities and funding, infrastructure, a network, educational measures and much more. All these can be found in the Programmes & Affiliates section, top right.
Facilities, funding and infrastructure
Researchers, teachers and students can join the incubators Amsterdam Venture Studios and Demonstrator Lab to develop and test their business cases or accommodate their start-up activities. HvA Bachelor students have access to the 10k Pre incubator program. Which offers coaching and guidance in developing innovative and/ or sustainable ideas into a start-up during a 20 week program. After completing 10K, participants will have gained knowledge, developed various products and are Startup Ready. After that they can join for instance Demonstrator Lab or AVS.
Students with plans for a start-up can profit from the knowledge of mentors through the platform Start Up and Running.
Companies and non-profits
Companies and non-profits can benefit from the latest scientific expertise and research facilities with the Physics on Demand service. The Research Facilities database helps R&D departments to find specialised, high-end equipment and instruments.
Teachers in Entrepreneurship can find inspiration for their education program and lessons with the Entrepreneurship cases and the BlendedLearning pilot. To keep HvA-alumni with their own business up to speed with the latest insights and knowledge the Post-Experience Program, with masterclasses and courses, was developed. For more information and upcoming masterclasses in the Post-Experience Program please send a E-mail.
A small fragment of a llama antibody, also called ‘nanobody’, is capable of reducing human cytomegalovirus (HCMV) in patients, scientists at the Vrije Universiteit and University of Cambridge found in a study. This could lower CMV-associated diseases and mortality during life-saving solid organ and stem cell transplantation and could be a potential lifesaving drug. HCMV […]News
Dr. Ronald van Steden enters into a partnership with the Dutch police. Together they are committed to guide and monitor the new position of ‘director care and safety’ (regisseur zorg en veiligheid) in Amsterdam. Dr. Ronald van Steden, Associate Professor of Public Administration at the Vrije Universiteit Amsterdam and Senior Researcher at the NSCR, has […]News
The project ChloroSpec, initiated by Alfred Holzwarth and Roberta Croce, establishes as BV. Lead by Peter Kievit (serial entrepreneur), ChloroSpec is a developer of plant health and stress analysis systems. ChloroSpec has developed a new technology that should become the gold standard in chlorophyll fluorescence monitoring of plants and algae, and analyzes how plants respond […]News